Galectin Therapeutics
GALT
GALT
80 hedge funds and large institutions have $34.4M invested in Galectin Therapeutics in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $35.4M → $34.4M (-$932K)
43% less call options, than puts
Call options by funds: $665K | Put options by funds: $1.17M
Holders
80
Holding in Top 10
–
Calls
$665K
Puts
$1.17M
Top Buyers
| 1 | +$1.3M | |
| 2 | +$924K | |
| 3 | +$294K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$289K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$189K |
Top Sellers
| 1 | -$614K | |
| 2 | -$144K | |
| 3 | -$121K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$111K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$72K |